- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/24 - Radicals substituted by oxygen atoms
Patent holdings for IPC class C07D 277/24
Total number of patents in this class: 302
10-year publication summary
|
16
|
22
|
16
|
22
|
21
|
18
|
13
|
12
|
13
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4742 |
9 |
| The University of Toledo | 432 |
8 |
| Oncternal Therapeutics, Inc. | 35 |
8 |
| Acucela Inc. | 153 |
7 |
| Avexxin AS | 41 |
7 |
| Gilead Sciences, Inc. | 2222 |
7 |
| University of Tennessee Research Foundation | 763 |
7 |
| Bayer Intellectual Property GmbH | 2364 |
6 |
| Sumitomo Chemical Company, Limited | 9016 |
6 |
| Kyoto University | 2904 |
6 |
| Toray Industries, Inc. | 7113 |
5 |
| F. Hoffmann-La Roche AG | 7837 |
4 |
| Centre National de La Recherche Scientifique | 11023 |
4 |
| Abbvie Inc. | 1836 |
4 |
| Shionogi & Co., Ltd. | 880 |
4 |
| Boehringer Ingelheim International GmbH | 4493 |
3 |
| Agency for Science, Technology and Research | 3733 |
3 |
| The Board of Trustees of the University of Illinois | 2751 |
3 |
| Purdue Research Foundation | 3916 |
3 |
| Atrogi AB | 58 |
3 |
| Other owners | 195 |